Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential ...

CDI‑988 is the first oral antiviral drug candidate being developed for prevention and treatment of norovirus ...

The first antiretroviral therapies (ARTs) for people with HIV were nucleoside reverse-transcriptase inhibitors (NRTIs), but these drugs were only partially effective. The addition of an orally ...

Pregnant women with HIV can be reassured that protease inhibitors are safer than previously thought in terms of risk to the foetus, according to research from the National Perinatal Epidemiology Unit ...

With the following convenient and accessible phosphatase and protease inhibitor cocktails, you can ensure the protection of your protein samples from degradation while also preserving their ...

Patent covers pristine graphene–based biosensor technology to translate protease activity into measurable optical ...

Efficient communication between cells is vital for many biological processes, such as recruiting immune cells to combat disease. The rapid release of at least 80 signaling molecules, including tumor ...

SARS Inhibited (2006) stands in the center of the science city Biopolis in Singapore. The bronze sculpture by Mara G. Haseltine depicts the three dimensional polypeptide backbone of the active site of ...

A recent study conducted by a team of US-based scientists has highlighted a novel function of 3C-like protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The protease has been ...

A University of Alberta research team has identified a new drug target to treat harmful E. coli bacteria—which cause nearly 250,000 deaths a year from urinary tract infections (UTI) and are becoming ...

Implementing a novel method to estimate the "Burden of Therapy" (BOTh) for patients with metastatic pancreatic cancer treated with gemcitabine plus afatinib vs. gemcitabine in the AIO ACCEPT trial.